The Magazine for Sleep Professionals
Thursday, February 5, 2026
Teneurin-3 appears to help wire the brain in mice to resist changes in sleep and other cycles linked to changing light Scientists at the Johns Hopkins University School of Medicine and the National Institutes of Health have identified a protein in the visual system of mice that appears to be […]
– SynAIRgy Compares AD109 to Placebo Over 6 Months in People with OSA who Are Intolerant of or Refuse Positive Airway Pressure (PAP) Therapy, the Current Standard of Care – Part of a two-study registrational Phase 3 program that also includes LunAIRo which began enrollment in September 2023 Apnimed, Inc., […]
NLS Pharmaceutics Ltd., a Swiss clinical-stage biopharmaceutical company focused on the discovery and development of innovative therapies for patients with rare and complex central nervous system (“CNS”) disorders, announced that NLS has entered into an exclusive worldwide option agreement with Aexon Labs, Inc., a privately held U.S. company (“Aexon Labs”), […]
Jazz Pharmaceuticals plc announced that the Company and its partners will present 14 abstracts from across its sleep medicine portfolio, including two oral presentations, at the 17th annual World Sleep 2023 Congress, held October 20-25 in Rio de Janeiro, Brazil. The oral presentations include findings from the real-world TENOR study, […]
Harmony Biosciences Holdings, Inc. announced the presentation of new secondary endpoint data, including improvements in behavioral disturbances, from its Phase 2 signal-detection study evaluating pitolisant for the treatment of excessive daytime sleepiness (EDS) in Prader-Willi syndrome (PWS) at the 2023 Foundation for Prader-Willi Research (FPWR) Symposium and Family Conference. The […]
Kingman Strohl, MD Obstructive sleep apnea (OSA) is effectively managed by positive airway pressure (PAP) applied to the nose and/or mouth. The principle of PAP is to inflate the critical region of closure in the upper airway, usually at the base of the tongue or the uvula. The effective property […]
Jazz Pharmaceuticals plc announced that six abstracts presenting data from across its sleep medicine portfolio were featured at the 36th annual Psych Congress, held September 6-10, 2023. One of the accepted abstracts provided a comprehensive review of clinical data that assessed the impact of oxybate on sleep quality, sleep architecture and […]
By Regina Patrick, RPSGT, RST Obstructive Sleep Apnea and Polycystic Ovary Syndrome Polycystic ovary syndrome (PCOS) is a disorder in which many small fluid-filled sacs (i.e., cysts) develop on a woman’s ovaries and the ovaries produce high levels of male sex hormones (i.e., androgens). PCOS is also associated with insulin […]
The National Sleep Foundation (NSF) and the Consumer Technology Association® (CTA) have released ANSI/CTA/NSF-2052.1-A Definitions and Characteristics for Wearable Sleep Monitors. Originally published in 2016, this updated standard further defines terms and functionality for sleep measuring devices. As a leader in sleep tech, NSF identified the need for standards for wearable […]
